Advances in Cancer Radiotherapy

Dear Colleagues,

Radiation therapy is an essential treatment option for cancer patients, as more than half of them will receive radiation as part of the therapeutic strategy during the course of disease. Technological advances and careful integration with surgery and systemic therapies allow for safe and effective delivery of radiotherapy in different oncological settings. Combination therapy allows for a detectable improvement in clinical outcomes, especially with the combined use of radiotherapy and immunotherapy or target agents. A deeper understanding of radiobiology also allows dissecting the molecular mechanisms underlying the interaction of radiotherapy and cellular mechanisms, tumor microenvironment and the immune system. The introduction of biomarkers allows for a better characterization of patient’s risk, to better tailor the therapeutic management.

Comprehensive cancer care, with a focus on treatment compliance, reduction in the toxicity profile related to treatment, patient’s quality of life and patient’s perspective fosters the role of radiotherapy in the multidisciplinary approach, typically suited to modern clinical oncology.

This collection is aimed at providing an overview of the role of radiotherapy in modern comprehensive and multidisciplinary cancer care.

Dr. Berardino De Bari
Dr. Letizia Deantonio
Dr. Pierfrancesco Franco
Collection Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.